Thirteen Fitzsimons Companies Selected to Present at Regional Life Science Conference

Companies from the Colorado Science + Technology Park at Fitzsimons will comprise about half of all presenters at this year’s Rocky Mountain Life Science Investor and Partnering Conference. Located at the Brown Palace Hotel in Downtown Denver, the event will feature 30 presenting companies. The conference is organized by the Colorado BioScience Association as the Rocky Mountain region’s premier investor and partner conference. Link to the news release pdf

MassDevice: 'Colorado Sen. to FDA: Regulatory science isn't enough'

Quoting from the posting:

"The FDA's newly minted plan to revamp its scientific methods isn't enough to ensure that the watchdog agency is doing its part in driving the global economy, according to junior Senator Michael Bennet (CO-D).

'I applaud the FDA's efforts to advance regulatory science through the recent release of the Agency's - Strategic Plan for Regulatory Science -but believe there is much more to be done,' Bennet wrote in a recent letter to FDA head Dr. Margaret Hamburg."

Further, on Monday (Aug 22) Senator Bennet brought FDA Commissioner Hamburg to Colorado, with two administration colleagues for a CEO Roundtable assembled by the Colorado BioScience Association at the Anschutz Medical Campus.

Link to the related CBSA Business Wire

Link to the related CBSA PitchEngine Social Media Release

Link to the MassDevice posting

CEO Roundtable: Senator Michael Bennet, FDA Commissioner Margaret Hamburg at Anschutz Medical Campus Yesterday

The Colorado BioScience Association (CBSA) worked with Senator Michael Bennet's office in assembling a group of more than 35 bioscience industry CEOs from its membership to dialogue with the Senator and Margaret Hamburg, M.D., Commissioner of the U.S. Food and Drug Administration (FDA). Dr. Jeffrey Shuren, Director, Center for Devices and Radiological Health, and Dr. Vicki Seyfert-Margolis, Senior Science Advisor to the FDA’s Chief Scientist, accompanied Commissioner Hamburg here.

The announcement is made by Holli Riebel (formerly Baumunk), CBSA President & CEO, who says "Senator Bennet invited Commissioner Hamburg and her colleagues to Colorado for the CEO Roundtable. The session is a positive next step to work CBSA has already contributed to Senator Bennet's Coloradoans For An Innovation Economy (CFAIE), and speaks strongly to the work the Senator is doing on our industry's behalf. We appreciate the opportunity to host Commissioner Hamburg in our state for the first time and share our industry's specific and unique needs for bringing innovative drugs and devices to market under current, often constraining, market conditions."

According to Lilly Marks, VP for Health Affairs and Executive Vice Chancellor, Anschutz Medical Campus, the Roundtable session took place on the Anschutz Medical Campus in Aurora where the FDA delegation also toured research and clinical trial facilities before departing the city.

Link to the Business Wire release

NCBR: 'Fort Collins companies to present at Denver science conference'

Quoting from the August 17th posting:

"DENVER - Three Fort Collins companies will present at the 2011 Rocky Mountain Life Science Investor and Partnering Conference, to be held at the Brown Palace Hotel, 321 17th St. in Denver Sept. 21 and 22. KromaTiD Inc., bioscience company focused on the creation of new products for chromosome analysis; Inviragen Inc., a vaccine development specialist; and VetDC Inc., which focuses on reverse-engineering human medicine to help treat animals, were selected to appear at the conference...The conference is presented by the Colorado Bioscience Association, and is expected to be attended by more than 50 national investment firms."

Link to ncbr.com

NMBW: 'Two New Mexico startups to present at investor conference'

Quoting from yesterday's posting:

"Two local startups, Avisa Pharma Inc. and Azano Pharmaceuticals, were among 30 companies selected to present at the Rocky Mountain Life Science Investor & Partnering Conference in Denver Sept. 21-22.

The two companies are developing and marketing new technologies licensed from the University of New Mexico to help cystic fibrosis and lupus patients."

Link to New Mexico Business Weekly

Daily Camera: "11 Boulder-area companies presenting at bioscience conference"

Quoting from the article by Alicia Wallace:

"Eleven companies from Boulder and Broomfield counties will present at the upcoming Rocky Mountain Life Science Investor and Partnering Conference in Denver, officials for the Colorado BioScience Association announced Tuesday.

The local firms will be among 30 companies to make presentations to industry investors and executives at the event scheduled for Sept. 21 and 22 at the Brown Palace Hotel, 321 17th St., in Denver. The companies and the attendees hail from Colorado, Arizona, Montana, New Mexico, Oklahoma, Utah and Canada."

Link to dailycamera.com

Thirty Regional Companies Selected to Present at the 2011 Rocky Mountain Life Science Investor & Partnering Conference in Denver

The 2011 Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC) will bring 30 of the region’s most innovative private and public life science companies together to present to a targeted audience of biotech, device, diagnostic and pharma investors and strategic partners. The conference is being held September 21-22 at The Brown Palace Hotel, Denver, CO.

Link to the Business Wire

Link to the Pitch Engine Social Media Newswire

CBSA Perspective: "Roche site in Boulder to be sold, operated as Corden Pharma"

Quoting from the Alicia Wallace report in the Boulder Daily Camera:

"The 265-person Roche Colorado site in Boulder is expected to be sold to International Chemical Investors Group, officials for both companies announced Wednesday....

'What's nice is it's such a specialized technical facility' that Roche still needs, said Holli Reibel, president and CEO of the Colorado BioScience Association. 'And (Corden) might really bring more product to the plant, which is excellent for Colorado.'

More and more, Reibel added, biotech and pharmaceutical companies have made moves to focus on their core capabilities and have opted to outsource manufacturing efforts elsewhere -- sometimes overseas. Corden Pharma, being a large contract manufacturer with an international reach, should be a welcome addition to Colorado's bioscience community, she said."

Link to the dailycamera.com coverage